Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CEFMENOXIME HYDROCHLORIDE NEW CRYSTALLINE FORM AND FORMULATION
Document Type and Number:
WIPO Patent Application WO/2017/140074
Kind Code:
A1
Abstract:
Disclosed are a cefmenoxime hydrochloride new crystalline compound and crystallization preparation method thereof; said cefmenoxime hydrochloride new crystalline compound is formed using particle processing for molecular assembly and morphological optimization of a crystalline product. The present compound has the features of high purity, good fluidity, and good stability. Also disclosed is a formulation -- cefmenoxime hydrochloride used for injection -- fabricated using the described cefmenoxime hydrochloride compound.

Inventors:
TAO LINGGANG (CN)
WANG JINGKANG (CN)
YIN QIUXIANG (CN)
HAO HONGXUN (CN)
Application Number:
PCT/CN2016/085307
Publication Date:
August 24, 2017
Filing Date:
June 08, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HAINAN LINGKANG PHARMACEUTICAL (CN)
UNIV TIANJIN (CN)
TAO LINGGANG (CN)
WANG JINGKANG (CN)
YIN QIUXIANG (CN)
HAO HONGXUN (CN)
International Classes:
C07D501/36; A61K31/546; A61P31/04; C07D501/06; C07D501/12
Foreign References:
CN101735249A2010-06-16
CN103159786A2013-06-19
CN102603772A2012-07-25
CN103554136A2014-02-05
CN105001239A2015-10-28
CN105566352A2016-05-11
Attorney, Agent or Firm:
BEIJING CONCEPT INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: